US biopharma company Kura Oncology secures financing of up to $150m
Listed on Nasdaq, Kura Oncology is engaged in developing small molecule drug candidates for the treatment of cancer
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Nov 22
Listed on Nasdaq, Kura Oncology is engaged in developing small molecule drug candidates for the treatment of cancer
03 Nov 22
So have a ball with these new small, round shapes that are inspired by the growing fandom for…
03 Nov 22
The current FDA approval expands Vemlidy’s previous indication as a once-daily therapy to treat chronic HBV infection in…
03 Nov 22
Foodhealth is the next massive category and bitewell has emerged as a corporate benefit pioneer by providing companies…
03 Nov 22
In addition, Simu will present an award celebrating the 150 millionth meal donated to Feeding America by BoxLunch…
03 Nov 22
The new facility will support the North American growth of Kinder Bueno, which Ferrero launched in the market in…
03 Nov 22
This is in keeping with a general trend in treating septic shock, says Perner, who says that care…
03 Nov 22
An amount of excised tissue is considered “enough” if no cancer cells are present at its outer edge,…
03 Nov 22
Exelixis expects each of the licenced antibodies to have the potential to be turned into an ADC or…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
02 Nov 22
If nothing else, that became clear during the pandemic, when 24% of British hospital patients contracted Covid in…